Supplemental oxygen therapy recommendations in patients with sickle cell disease during air travel: A cross-sectional survey of North American health care providers | Zendy

Amarjot Padda | Zendy; Catherine CorriveauBourque | Zendy; Mark Belletrutti | Zendy; Aisha Bruce | Zendy

Open Access

Supplemental oxygen therapy recommendations in patients with sickle cell disease during air travel: A cross-sectional survey of North American health care providers

Author(s) -

Amarjot Padda,

Catherine CorriveauBourque,

Mark Belletrutti,

Aisha Bruce

Publication year - 2019

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.55

H-Index - 43

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/pxz049

Subject(s) - medicine , air travel , supplemental oxygen , hemoglobinopathy , cross sectional study , disease , family medicine , intensive care medicine , pathology , aviation , engineering , aerospace engineering

Air travel may expose patients with sickle cell disease (SCD) to an increased risk of disease-related complications. Several factors are felt to contribute including prolonged hypoxia, dehydration, temperature changes, and stress. The Canadian Paediatric Society (CPS) position statement, published in 2007, recommends that SCD patients use supplemental oxygen on flights. While the National Heart, Lung and Blood Institute (NHLBI) recommend that SCD patients dress warmly, stay hydrated, and move about the cabin. Other guidelines do not make specific recommendations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research